Physician, Scientist, Inventor, Entrepreneur, Husband, Father & Grandfather. My personal mantra: Saving lives one invention at a time.
Los Angeles, CA
Joined July 2009
- Tweets73.4K
- Following7.8K
- Followers16.3K
- Likes34.4K
Pinned Tweet
Wearables and the Electrophysiology Practice: Challenges and Opportunities eplabdigest.com/wearables-an… via @khaldountarakji
All 4 of our children (all adults now) have been teachers at various levels. This is the latest example. Teaching is a critical profession so this makes us proud parents. @MichaelAlbertMD
David E. Albert, M.D retweeted
In our State-of-the-Art Review @AJPCardio, we provide a comprehensive overview of changes in lipid profiles throughout a women’s lifespan along with management considerations reinforced in the 2026 Dyslipidemia Guideline
💃Wonderful work led by Drs Bhavya Shah, @DianeMasket @n_marreromed @TinaKReddy
#womenshealth #womenshearthealth #lipidsmanagementacrossthelifespan
🔗sciencedirect.com/science/ar…
There is so much more valuable information in a 6-lead ECG than a 1-lead. The superiority of 6 leads in the diagnosis of AFib and the ability to diagnose Atrial Flutter (normally invisible in Lead I) are just two of them. #AliveCor #Kardia6L pubmed.ncbi.nlm.nih.gov/3585…
David E. Albert, M.D retweeted
Cannabis legalisation and cardiovascular hospitalisations in the United States: nationwide difference-in-differences analysis, 2012–2018 bmjopen.bmj.com/content/16/1…
David E. Albert, M.D retweeted
🔬Join us at @AHAScience Scientific Sessions from November 7-9 in Chicago as we showcase the award-winning Kardia 12L — an FDA-cleared, 12-lead ECG system that’s lighter than a smartphone and fits in a lab coat pocket.
Our founder, @DrDave01, will also be joining as a panelist on The State of Health Innovation 2026 on November 7 to explore the friction points, breakthroughs, and realities shaping AI’s role in care delivery.
📍Visit us at booth #HIP 1 in the Health Innovation Pavilion to meet the team, explore our clinically validated solutions, and see how they enable critical heart data capture—anytime, anywhere.
#ScientificSessions26 #AHA26 #ECG #CardiacMonitoring #HealthTech #MedTech #AI #AliveCor #Healthcare #DigitalHealth #Cardiology #Conference
David E. Albert, M.D retweeted
“I’m good at this, but my colleagues could benefit from this AI.”
A sentiment we often hear at conferences. Yet ECG quizzes and studies consistently reveal a gap between perceived and actual ability to recognize STEMI/OMI.
Recognizing our own limitations takes humility.
David E. Albert, M.D retweeted
56M w 1-month DOE
Today, Acute CP
Ctnl 0
Dx?
@akneton @yolyabreuh @UlhasDr @DidlakeDW @ecgrhythms @IhabFathiSulima @DrPharmDMDTh
@Vadeboncoeur_Al @smithECGBlog @EM_RESUS @estudiomedicina @OrlandoRPN @fxgodzeuss #FOAMcc @ResusMed @TrRja @NaokiThukishima @ecgandrhythmRoe
David E. Albert, M.D retweeted
Insurance requiring a trial of stimulants before GLP-1 is dumbest concept ever.
"Yes, you need to try the lesser effective and more dangerous medicine first."
David E. Albert, M.D retweeted
Eating 800-1200 kcals daily and not losing weight is physiologically implausible.
That said, I don't think people are necessarily lying about their intake. Humans simply didn't evolve to be accurate calorimeters.
David E. Albert, M.D retweeted
Them: ApoB didn't correlate with plaque progression.
Us: Wait...that wasn't your preregistered primary outcome.
Them: Plaque begets plaque
Us: Wait...your study shows LMHRs have historically high plaque progression.
Them: The data is wrong because our vendor sucks.
Us: Why did you go on a historic marketing campaign and produce a documentary?
Them: We retracted our paper. All good.
Us : That's not how this works.
David E. Albert, M.D retweeted
Spending the weekend writing my exposé on the KETO-CTA disaster.
Working title: Retracted Wednesday. Premiered Saturday.
The OGs will know exactly what that means. Revisiting the saga feels like being gaslit all over again.
Hoping to publish next week.
Only at: read.michaelalbertmd.com
David E. Albert, M.D retweeted
Rhythm?
@akneton @yolyabreuh @UlhasDr
@DidlakeDW @ecgrhythms @IhabFathiSulima
@DrPharmDMDTh @Vadeboncoeur_Al @smithECGBlog
@EM_RESUS @estudiomedicina @OrlandoRPN @fxgodzeuss #EPeeps #FOAMcc @ResusMed @TrRja @NaokiThukishima @ecgandrhythmRoe
David E. Albert, M.D retweeted
Who’s heading to #TCT2026 this year? 😎 Two exciting multicenter studies will be presented!
Every minute matters when a coronary artery is occluded. 🫀
Meet the team behind Queen of Hearts™ at #TCT2026 for a live demo of AI-powered ECG analysis, now FDA De Novo authorized.
📍 San Diego | Booth #3125
📅 Oct 31 – Nov 3
#PMcardio #Cardiology
David E. Albert, M.D retweeted
39M
SOB Post-Chest Infection
HsTn 22
DD >2K
BNP >5K
fT4 18
Dx?
@akneton @yolyabreuh @DidlakeDW @ecgrhythms @IhabFathiSulima @DrPharmDMDTh @Vadeboncoeur_Al @smithECGBlog @EM_RESUS @estudiomedicina @OrlandoRPN @fxgodzeuss #FOAMcc @ResusMed @TrRja @NaokiThukishima @ecgandrhythmRoe
David E. Albert, M.D retweeted
I’ve taken care of many of such “bodybuilders” who have killed themselves with exogenous, antibiotic, steroids, and other agents!
David E. Albert, M.D retweeted
We’re honored to be named to @TIME's World’s Top HealthTech Companies list for 2026—marking our second consecutive year among the global leaders transforming healthcare.🏆
In a crowded market of heart monitoring solutions, back-to-back recognition from TIME speaks volumes. From advancing personal ECG technology to scaling clinical-grade cardiac AI worldwide, it reinforces why AliveCor continues to lead, innovate, and cut through the noise.🥇
🔗Explore the full ranking on TIME: time.com/article/2026/09/16/…
#HealthTech #Innovation #Healthcare #TIME #Awards #DigitalHealth #HealthcareInnovation #Cardiology #CardiacAI
David E. Albert, M.D retweeted
Retatrutide, the most potent GLP-1 agent in this family of drugs to date, had a marked benefit vs sleep apnea in a randomized trial, in people with obesity, just published @NEJM AHI-apnea-hypopnea index
nejm.org/doi/full/10.1056/NE…
